565
Views
33
CrossRef citations to date
0
Altmetric
Research Article

Probiotics in the Management of Irritable Bowel Syndrome: A Review of Clinical Trials

Pages 212-216 | Published online: 11 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Monika Sharma & Mridula Devi. (2014) Probiotics: A Comprehensive Approach toward Health Foods. Critical Reviews in Food Science and Nutrition 54:4, pages 537-552.
Read now
Stephen M Vindigni, Elizabeth K Broussard & Christina M Surawicz. (2013) Alteration of the intestinal microbiome: fecal microbiota transplant and probiotics for Clostridium difficile and beyond. Expert Review of Gastroenterology & Hepatology 7:7, pages 615-628.
Read now
Eamonn MM Quigley. (2009) Prebiotics for irritable bowel syndrome. Expert Review of Gastroenterology & Hepatology 3:5, pages 487-492.
Read now
Eamonn M M Quigley. (2007) Probiotics in Irritable Bowel Syndrome: An Immunomodulatory Strategy?. Journal of the American College of Nutrition 26:6, pages 684S-690S.
Read now
Jeanne Drisko, Bette Bischoff, Matthew Hall & Richard McCallum. (2006) Treating Irritable Bowel Syndrome with a Food Elimination Diet Followed by Food Challenge and Probiotics. Journal of the American College of Nutrition 25:6, pages 514-522.
Read now

Articles from other publishers (28)

Eamonn M.M. Quigley. 2016. Probiotics, Prebiotics, and Synbiotics. Probiotics, Prebiotics, and Synbiotics 549 556 .
Angela A Huertas-Ceballos, Stuart Logan, Cathy Bennett, Colin Macarthur & Alice E Martin. (2014) Pharmacological interventions for recurrent abdominal pain (RAP) and irritable bowel syndrome (IBS) in childhood. Cochrane Database of Systematic Reviews.
Crossref
Eamonn M.M. Quigley. (2012) Probiotics in the Management of Functional Bowel Disorders. Gastroenterology Clinics of North America 41:4, pages 805-819.
Crossref
Sonia Michail & Harshavardhan Kenche. (2010) Gut Microbiota is Not Modified by Randomized, Double-Blind, Placebo-Controlled Trial of VSL#3 in Diarrhea-Predominant Irritable Bowel Syndrome. Probiotics and Antimicrobial Proteins 3:1, pages 1-7.
Crossref
Marie-Agnès Travers, Isabelle Florent, Linda Kohl & Philippe Grellier. (2011) Probiotics for the Control of Parasites: An Overview. Journal of Parasitology Research 2011, pages 1-11.
Crossref
Michael de Vrese & B. Offick. 2010. Bioactive Foods in Promoting Health. Bioactive Foods in Promoting Health 205 227 .
Ashraf MORCOS, Ted DINAN & Eamonn MM QUIGLEY. (2009) Irritable bowel syndrome: Role of food in pathogenesis and management. Journal of Digestive Diseases 10:4, pages 237-246.
Crossref
Hannah Claire Baker, Dang Ngoc Tran & Linda Valerie Thomas. (2009) Health benefits of probiotics for the elderly: a review. Journal of Foodservice 20:5, pages 250-262.
Crossref
Sonia Michail. 2009. Probiotics in Pediatric Medicine. Probiotics in Pediatric Medicine 131 145 .
María Carmen Collado & Yolanda Sanz. 2008. New Strategies Combating Bacterial Infection. New Strategies Combating Bacterial Infection 275 295 .
Angela A Huertas-Ceballos, Stuart Logan, Cathy Bennett & Colin Macarthur. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Eamonn M. M. Quigley. (2007) Probiotics in the management of colonic disorders. Current Gastroenterology Reports 9:5, pages 434-440.
Crossref
Eamonn M.M. Quigley. (2007) Bacteria: A New Player in Gastrointestinal Motility Disorders—Infections, Bacterial Overgrowth, and Probiotics. Gastroenterology Clinics of North America 36:3, pages 735-748.
Crossref
Michael J.G. Farthing. (2007) The patient with refractory diarrhoea. Best Practice & Research Clinical Gastroenterology 21:3, pages 485-501.
Crossref
e. m. m. quigley & b. flourie. (2007) Probiotics and irritable bowel syndrome: a rationale for their use and an assessment of the evidence to date. Neurogastroenterology & Motility 19:3, pages 166-172.
Crossref
Eamonn M M QUIGLEY. (2007) Bacterial flora in irritable bowel syndrome: role in pathophysiology, implications for management. Journal of Digestive Diseases 8:1, pages 2-7.
Crossref
E. Myllyluoma, K. Kajander & M. Saxelin. 2007. Functional Dairy Products. Functional Dairy Products 63 89 .
l. bueno, f. de ponti, m. fried, g. a. kullak-ublick, m. a. kwiatek, d. pohl, e. m. m. quigley, j. tack & n. j. talley. (2007) Serotonergic and non-serotonergic targets in the pharmacotherapy of visceral hypersensitivity. Neurogastroenterology & Motility 19:s1, pages 89-119.
Crossref
H. Mönnikes, M. Schmidtmann & I. R. van der Voort. (2006) Arzneimitteltherapie des ReizdarmsyndromsDrug therapy for irritable bowel syndrome. Der Internist 47:10, pages 1073-1083.
Crossref
Peter J Whorwell, Linda Altringer, Jorge Morel, Yvonne Bond, Duane Charbonneau, Liam O'Mahony, Barry Kiely, Fergus Shanahan & Eamonn M M Quigley. (2006) Efficacy of an Encapsulated Probiotic Bifidobacterium infantis 35624 in Women with Irritable Bowel Syndrome. The American Journal of Gastroenterology 101:7, pages 1581-1590.
Crossref
C. PICARD, J. FIORAMONTI, A. FRANCOIS, T. ROBINSON, F. NEANT & C. MATUCHANSKY. (2005) Review article: bifidobacteria as probiotic agents - physiological effects and clinical benefits. Alimentary Pharmacology and Therapeutics 22:6, pages 495-512.
Crossref
Eamonn M.M. Quigley. (2005) The Use of Probiotics in Functional Bowel Disease. Gastroenterology Clinics of North America 34:3, pages 533-545.
Crossref
Michael J. G. Farthing. (2005) Functional diarrhea. Current Gastroenterology Reports 7:5, pages 350-357.
Crossref
A. SULLIVAN & C. E. NORD. (2005) Probiotics and gastrointestinal diseases. Journal of Internal Medicine 257:1, pages 78-92.
Crossref
J. Hamilton-Miller. (2004) Probiotics: health benefits for the over 50s. Nutrition Bulletin 29:4, pages 353-355.
Crossref
J M T Hamilton-Miller. (2004) Probiotics and prebiotics in the elderly. Postgraduate Medical Journal 80:946, pages 447-451.
Crossref
Michael J.G. Farthing. (2004) Treatment options in irritable bowel syndrome. Best Practice & Research Clinical Gastroenterology 18:4, pages 773-786.
Crossref
H. J. Kim, M. Camilleri, S. Mckinzie, M. B. Lempke, D. D. Burton, G. M. Thomforde & A. R. Zinsmeister. (2003) A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome. Alimentary Pharmacology & Therapeutics 17:7, pages 895-904.
Crossref